Author:
Dispenzieri A,D'Souza A,Gertz M A,Laumann K,Wiseman G,Lacy M Q,LaPlant B,Buadi F,Hayman S R,Kumar S K,Dingli D,Hogan W J,Ansell S M,Gastineau D A,Inwards D J,Micallef I N,Porrata L F,Johnston P B,Litzow M R,Witzig T E
Publisher
Springer Science and Business Media LLC
Subject
Transplantation,Hematology
Reference38 articles.
1. Attal M, Harousseau JL, Stoppa AM, Sotto JJ, Fuzibet JG, Rossi JF et al. A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. Intergroupe Francais du Myelome. N Engl J Med 1996; 335: 91–97.
2. Child JA, Morgan GJ, Davies FE, Owen RG, Bell SE, Hawkins K et al. High-dose chemotherapy with hematopoietic stem-cell rescue for multiple myeloma. N Engl J Med 2003; 348: 1875–1883.
3. Voorhees PM, Usmani SZ . The role of high-dose melphalan and autologous stem cell transplant in the rapidly evolving era of modern multiple myeloma therapy. Clin Adv Hematol Oncol 2016; 14: 719–728.
4. Attal M, Lauwers-Cances V, Hulin C, Leleu X, Caillot D, Escoffre M et al. Lenalidomide, bortezomib, and dexamethasone with transplantation for myeloma. N Engl J Med 2017; 376: 1311–1320.
5. Gay F, Oliva S, Petrucci MT, Montefusco V, Conticello C, Musto P et al. Autologous transplant vs oral chemotherapy and lenalidomide in newly diagnosed young myeloma patients: a pooled analysis. Leukemia 2017; 31: 1727–1734.
Cited by
13 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献